Tirzepatide 10mg from Kensington Labs achieved 99.536% purity in independent HPLC analysis conducted by Janoshik Labs on September 12, 2025. The tested quantity of 11.78mg exceeds the labeled 10mg specification, indicating accurate labeling and manufacturing quality.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. A purity level of 99.536% confirms minimal contamination and high-grade synthesis quality.
The full certificate of analysis is available for verification at www.janoshik.com/verify/ using the unique key E2S6QN3IUX4G.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.